The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vanaja Kuchipudi, Jeevan Kuchipudi and Krishna Kuchipudi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.4 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Four members of the promoter group of Jeevan Scientific Technology Ltd — Vanaja Kuchipudi, Snigdha Mothukuri (Executive Director), Krishna Kishore Kuchipudi (Managing Director), and Jeevan Krishna Kuchipudi (Non-Executive Director) — acquired Convertible Warrants via a preferential issue on January 2, 2026. Krishna Kishore Kuchipudi got 12,00,000 warrants while the other three each received 6,00,000 warrants, taking total warrants issued to the promoter group to 30,00,000. After the allotment, Krishna Kishore Kuchipudi's combined holding (shares + warrants) stands at 33,35,113 units (14.24% on diluted basis), Vanaja Kuchipudi at 21,73,800 (9.28%), Jeevan Krishna Kuchipudi at 15,17,772 (6.48%), and Snigdha Mothukuri at 6,78,500 (2.90%). The company's equity share capital rose from Rs. 15.83 crore to Rs. 19.92 crore through the preferential issue, with fully diluted capital at Rs. 23.42 crore.
This signals promoter confidence and capital infusion into the company via preferential warrants, which is generally viewed positively by retail investors as it shows insider belief in the business. However, dilution from conversion of warrants could pressure share value later, and the promoter group remains below 50% of voting capital on a non-diluted basis.